Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of EUR 130.52 billion. The enterprise value is 141.23 billion.
Market Cap | 130.52B |
Enterprise Value | 141.23B |
Important Dates
The last earnings date was Thursday, January 30, 2025.
Earnings Date | Jan 30, 2025 |
Ex-Dividend Date | May 13, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.02% |
Shares Change (QoQ) | +0.05% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.13B |
Valuation Ratios
The trailing PE ratio is 23.48.
PE Ratio | 23.48 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 6.57 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.73, with an EV/FCF ratio of 23.99.
EV / Earnings | 25.40 |
EV / Sales | 3.19 |
EV / EBITDA | 11.73 |
EV / EBIT | 15.82 |
EV / FCF | 23.99 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.23.
Current Ratio | 1.46 |
Quick Ratio | 0.62 |
Debt / Equity | 0.23 |
Debt / EBITDA | 1.50 |
Debt / FCF | 3.04 |
Interest Coverage | 13.84 |
Financial Efficiency
Return on equity (ROE) is 7.30% and return on invested capital (ROIC) is 5.88%.
Return on Equity (ROE) | 7.30% |
Return on Assets (ROA) | 4.28% |
Return on Invested Capital (ROIC) | 5.88% |
Return on Capital Employed (ROCE) | 8.56% |
Revenue Per Employee | 534,352 |
Profits Per Employee | 67,087 |
Employee Count | 82,878 |
Asset Turnover | 0.34 |
Inventory Turnover | 1.38 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.37% in the last 52 weeks. The beta is 0.46, so Sanofi's price volatility has been lower than the market average.
Beta (5Y) | 0.46 |
52-Week Price Change | +19.37% |
50-Day Moving Average | 97.98 |
200-Day Moving Average | 96.22 |
Relative Strength Index (RSI) | 61.50 |
Average Volume (20 Days) | 5,900 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of EUR 44.29 billion and earned 5.56 billion in profits. Earnings per share was 4.44.
Revenue | 44.29B |
Gross Profit | 31.09B |
Operating Income | 8.87B |
Pretax Income | 6.76B |
Net Income | 5.56B |
EBITDA | 11.66B |
EBIT | 8.87B |
Earnings Per Share (EPS) | 4.44 |
Balance Sheet
The company has 7.56 billion in cash and 17.91 billion in debt, giving a net cash position of -10.36 billion.
Cash & Cash Equivalents | 7.56B |
Total Debt | 17.91B |
Net Cash | -10.36B |
Net Cash Per Share | n/a |
Equity (Book Value) | 77.86B |
Book Value Per Share | 61.83 |
Working Capital | 13.43B |
Cash Flow
In the last 12 months, operating cash flow was 9.08 billion and capital expenditures -3.20 billion, giving a free cash flow of 5.89 billion.
Operating Cash Flow | 9.08B |
Capital Expenditures | -3.20B |
Free Cash Flow | 5.89B |
FCF Per Share | n/a |
Margins
Gross margin is 70.21%, with operating and profit margins of 20.03% and 12.55%.
Gross Margin | 70.21% |
Operating Margin | 20.03% |
Pretax Margin | 15.26% |
Profit Margin | 12.55% |
EBITDA Margin | 26.34% |
EBIT Margin | 20.03% |
FCF Margin | 13.29% |
Dividends & Yields
This stock pays an annual dividend of 3.76, which amounts to a dividend yield of 3.61%.
Dividend Per Share | 3.76 |
Dividend Yield | 3.61% |
Dividend Growth (YoY) | 5.62% |
Years of Dividend Growth | 1 |
Payout Ratio | 84.60% |
Buyback Yield | 0.02% |
Shareholder Yield | 3.63% |
Earnings Yield | 4.26% |
FCF Yield | 4.51% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |